# US 2024/0390888 A1 · Blood test device

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0390888 A1
- Document ID: US20240390888A1
- Status: Published application
- Kind: A1
- Application number: 18/796,295
- Filed: 2024-08-07
- Published: 2024-11-28
- Earliest claimed: 2022-02-24
- Assignees: Cellspect Co., Ltd.
- Applicants: Cellspect Co., Ltd.
- Inventors: Seung Kyum KIM; Takashi ITO; Tomohiko EDURA
- Web page: https://patentgrep.com/patent/US20240390888A1

## CPC

- B01L 3/5023: {with a sample being transported to, and subsequently stored in an absorbent for analysis}
- G01N 33/525: {Multi-layer analytical elements}
- G01N 33/52: Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper {and including single- and multilayer analytical elements (immunological elements G01N33/54386; involving labelled immunochemicals G01N33/58; for haemoglobin or occult blood G01N33/72)}
- B01L 2200/16: Reagents, handling or storing thereof
- B01L 2300/0681: Filter
- B01L 2300/069: Absorbents; Gels to retain a fluid
- B01L 2300/0825: Test strips
- B01L: CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

A blood test device includes a first substrate with the first opening where the blood is added; a second substrate arranged opposite the first substrate, with a second opening to observe the color reaction; the dry reagent phase laminated on the second surface between the first substrate and the second substrate so that a part of the dry reagent phase is exposed from the second opening; a plasma separation part formed by a porous sheet material and laminated on the dry reagent phase; and a diffusion layer formed by a sheet of hydrophilic fibers and arranged on the plasma separation part so that a part of the diffusion layer is exposed from the first opening, wherein an area of a surface of the plasma separation part on dry reagent phase side, the area being outside a section in contact with the dry reagent phase, is bonded to the second substrate.

## Claims

### Claim 1

A blood test device for measuring the presence or concentration of a specific substance in blood based on a color reaction that occurs in a dry reagent phase impregnated with a reagent by bringing plasma separated from the blood into contact with the dry reagent phase, comprising:
a first substrate with the first opening where the blood is to be added;
a second substrate arranged opposite the first substrate, with a second opening to observe the color reaction;
the dry reagent phase laminated on the second surface between the first substrate and the second substrate so that a part of the dry reagent phase is exposed from the second opening;
a plasma separation part formed by a porous sheet material and laminated on the dry reagent phase; and
a diffusion layer formed by a sheet of hydrophilic fibers and arranged on the plasma separation part so that a part of the diffusion layer is exposed from the first opening,
wherein an area of a surface of the plasma separation part on the dry reagent phase side, the area being outside a section in contact with the dry reagent phase, is bonded to the second substrate.

### Claim 2 (depends on 1)

The blood test device according to claim 1, wherein a ratio of the volume of the plasma separation part to the volume of the dry reagent phase is between 1.6 times and 3.7 times, inclusive.

### Claim 3 (depends on 1)

The blood test device according to claim 1, wherein
a plurality of the second openings is provided,
a plurality of the dry reagent phases is provided, and
the ratio of the volume of the plasma separation part to the sum of the volumes of the dry reagent phases is between 1.6 times and 3.7 times, inclusive.

### Claim 4 (depends on 2)

The blood test device according to claim 2, wherein the ratio is between 2.0 times and 3.1 times, inclusive.

### Claim 5 (depends on 3)

The blood test device according to claim 3, wherein the ratio is between 2.0 times and 3.1 times, inclusive.

### Claim 6 (depends on 1)

The blood test device according to claim 1, further comprising a spacer for forming a space with a predetermined height between the first substrate and the second substrate, the spacer being arranged between the first substrate and the second substrate,
wherein the dry reagent phase, the plasma separation part, and the diffusion layer are arranged in the space, and
the height of the spacer is less than the sum of the thickness of the diffusion layer, the thickness of the plasma separation part, and the thickness of the dry reagent phase, in the state before assembly of the blood test device.

### Claim 7 (depends on 6)

The blood test device according to claim 6, wherein the height of the spacer is between 0.65 times and 0.9 times the sum, inclusive.

### Claim 8 (depends on 1)

The blood test device according to claim 1, wherein the plasma separation part includes a polysulfone membrane or an asymmetric polysulfone membrane.
